Fuda Cancer Hospital-Combined Immunotherapy for Cancer (CIC)

Fuda Cancer Hospital-Combined Immunotherapy for Cancer (CIC)

CIC is the combination of several immune techniques to increase/stimulate systemic immune function. Some of them is to upgrade the function of T cells and/or B cells, some of them is to upgrade the function of DC, NK cells, macrophages and various kinds of cytokines. The combination is able to destroy or inhibit cancer cells regardless of what kind of cancer and the variability/mutation of cancer cells.

The main procedures are as follow:
– At 1st day: 60-80ml of whole blood are collected intravenously, and it sent to laboratory for cells isolation and culture
– At 8th-12th day: intravenous re-infusion injected subcutaneously on shoulder or the area near the tumor. MV is weekly injected, and the dosage is from 0.5mil to 1.5ml depending on the injected local skin response. This is repeated for three weeks followed by a two week’s break. The cycle is repeated for three months
– At 1st day: 0.5-1ml of Interleukin II (IL-2) is injected on an acupucture point, it is also weekly used
– At 1st day: 2.5mg of LDN is taken orally when go to bed every night, it is a long term use
– Chinese traditional medicine is taken orally

Advantages of CIC
– Very little side effect
– Broad spectrum anti tumor effects
– An effective measure for prevention of cancer relapse

For more information please visit Fuda Cancer Hospital official website:
http://www.fudahospital.com/